advertisement

Topcon

Yohannan J 12

Showing records 1 to 12 | Display all abstracts from Yohannan J

112919 The impact of achieving target intraocular pressure on glaucomatous retinal nerve fiber layer thinning in a treated clinical population
Pham AT
American Journal of Ophthalmology 2024; 262: 213-221
111926 Prediction of MIGS outcomes on second eyes using first eyes' response
Dickinson A
Medicine 2023; 102: e36006
112919 The impact of achieving target intraocular pressure on glaucomatous retinal nerve fiber layer thinning in a treated clinical population
Bradley C
American Journal of Ophthalmology 2024; 262: 213-221
111926 Prediction of MIGS outcomes on second eyes using first eyes' response
Leidy L
Medicine 2023; 102: e36006
112919 The impact of achieving target intraocular pressure on glaucomatous retinal nerve fiber layer thinning in a treated clinical population
Hou K
American Journal of Ophthalmology 2024; 262: 213-221
111926 Prediction of MIGS outcomes on second eyes using first eyes' response
Nusair O; Rachapudi S
Medicine 2023; 102: e36006
112919 The impact of achieving target intraocular pressure on glaucomatous retinal nerve fiber layer thinning in a treated clinical population
Herbert P; Boland MV
American Journal of Ophthalmology 2024; 262: 213-221
111926 Prediction of MIGS outcomes on second eyes using first eyes' response
Valenzuela T; Ramulu P
Medicine 2023; 102: e36006
112919 The impact of achieving target intraocular pressure on glaucomatous retinal nerve fiber layer thinning in a treated clinical population
Ramulu PY
American Journal of Ophthalmology 2024; 262: 213-221
111926 Prediction of MIGS outcomes on second eyes using first eyes' response
Mihailovic A
Medicine 2023; 102: e36006
112919 The impact of achieving target intraocular pressure on glaucomatous retinal nerve fiber layer thinning in a treated clinical population
Yohannan J
American Journal of Ophthalmology 2024; 262: 213-221
111926 Prediction of MIGS outcomes on second eyes using first eyes' response
Yohannan J; Kaleem M; Johnson TV; An J
Medicine 2023; 102: e36006

Issue 24-3

Change Issue


advertisement

Oculus